Franchise Head Onkologie - Gastrointestinal Cancer (m/f/d)

Gastrointestinal tumors are among the most urgent challenges of cancer medicine. AstraZeneca pursues the clear vision of eliminating cancer as a cause of death - with a strong, broad and scientifically based GI portfolio. As Franchise Head (m/w/d) Oncology - Gastrointestinal (GI) Tumors take over the strategic leadership of this central area and bring innovations into care. This role is aimed at leaders who take responsibility and want to make real progress for patients. As Franchise Head (m/w/d), you are responsible for a portfolio that combines scientific innovation, utilities and market dynamics. You are part of the oncology leadership team and are shaping our area strategically and operationally. This role requires leadership that creates clarity, prioritizes and empowers teams to effectively use their strengths. You develop people, promote synergies and align resources to what makes the greatest difference. If you are looking for a task in which you will give direction, effect and take responsibility for a portfolio that is central to patients as well as for our future, you will set standards in this role. Your tasks:

• Commercial leadership of the franchise Total responsibility for the commercial management of the therapy area, including P&L-relevant decisions Further development of the market and competition strategy and its operational implementation Preparation and control of product introductions Responsibility for lifecycle management and identification of further development opportunities in the portfolio
• Relationship and stakeholder management Building and maintaining a resilient network with key opinion leaders and other relevant experts: Close cooperation with regional and global teams to coordinate strategies, priorities and market impulses Coordination with internal functions such as Medical, Market Access and Corporate Affairs to ensure a consistent and strong franchise presence
• Leadership and cooperation Management and further development of marketing and sales teams Promoting talent and building a sustainable talent pipeline Strengthening cross-functional cooperation and use of synergies Active role in the oncology leadership team: Responsibility for the further development of the overall portfolio and the orientation of the area beyond its own franchise

Strengths prove: Completed economic, scientific or comparable studies, ideally with further qualification (Master, Promotion, MBA) Multiannual experience in oncology or haematology in a responsible, commercial role Funded experience in controlling complex markets and in developing and implementing therapeutic area strategies Outstanding leadership and experience in the development of teams and talents routine in cooperation with different internal and external stakeholders, including KOLs and global/regional functions Analytical strength, decision-making and sovereign handling of dynamic framework conditions Understanding international practices and embedding national activities in higher-level relationships Safe appearance, persuasiveness and enthusiasm in difficult situations as well as situation-oriented use of leadership styles Visionary and at the same time targeting and engaging personality Passion and absolute result orientation as well as the will and ambition for personal development Excellent presentation skills as well as excellent German and English skills

It offers: an attractive pipeline and innovative products individual development opportunities and the focus on lifelong learning lots of trust, appreciation and space for co-design in a focused and passionate team Office space in the heart of Hamburg, which enables collaborative, flexible and agile cooperation a diverse, inclusive and prejudice-free working environment, committed to the Charter of Diversity, not only allows differences, but actively promotes and welcomes and takes into account applications from all qualified applicants, regardless of their characteristics a sustainable company that becomes CO2 negative by 2030 along the entire value chain

AstraZeneca in Oncology & Haematology AstraZeneca is one of the world's leading companies in oncology and hematology. Our focus is on fundamentally improving the treatment of cancer and helping to eliminate cancer as a cause of death in the long term. Our research and development includes a wide range of innovative therapeutic approaches, including precision medicine, immunooncology, antibody-active conjugates, DNA repair mechanisms and cell- and molecular-based technologies. With a strong presence in large tumours such as breast cancer, lung cancer, genitourinary and gynecological tumors, hematological and gastrointestinal cancers, we develop therapies that combine clinical innovation, evidence and supply reality. Our aim is to bring scientific knowledge to the care that it is able to benefit patients in a tangible way and to extend the treatment possibilities worldwide. .